Synthesis and biological evaluation of 1-azabicyclo-[3.2.1]octanes: New dopamine transporter inhibitors

Amir P. Tamiz, Miles P. Smith, Istvan Enyedy, Judith Flippen-Anderson, Mei Zhang, Kenneth M. Johnson, Alan P. Kozikowski

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

The synthesis and biological activity of a series of 6-substituted 1-azabicyclo[3.2.1]octanes are described. 1-Azabicyclo[3.2.1]octanes represent a new class of compounds that exhibit monoamine transporter inhibitory activity highly dependent on the overall topology and the absolute stereochemistry of the molecule. (C) 2000 Elsevier Science Ltd. All rights reserved.

Original languageEnglish (US)
Pages (from-to)1681-1686
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume10
Issue number15
DOIs
StatePublished - Aug 7 2000

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Synthesis and biological evaluation of 1-azabicyclo-[3.2.1]octanes: New dopamine transporter inhibitors'. Together they form a unique fingerprint.

  • Cite this

    Tamiz, A. P., Smith, M. P., Enyedy, I., Flippen-Anderson, J., Zhang, M., Johnson, K. M., & Kozikowski, A. P. (2000). Synthesis and biological evaluation of 1-azabicyclo-[3.2.1]octanes: New dopamine transporter inhibitors. Bioorganic and Medicinal Chemistry Letters, 10(15), 1681-1686. https://doi.org/10.1016/S0960-894X(00)00308-5